What Does Europe’s New Review Reveal About Trans Healthcare Rights?
New European research examines transgender healthcare access, court decisions, insurance disputes and treatment inequalities across EU countries.
Access to transgender healthcare remains inconsistent across Europe, with a new legal review highlighting how court decisions can determine whether patients receive treatment, obtain financial support or face further restrictions.
Published on 5 November by transgender rights organisation TGEU, the review examines national court cases involving healthcare funding, waiting lists, age restrictions and discrimination.
It also considers disputes over patients travelling abroad for treatment when appropriate healthcare is unavailable or difficult to access in their home country.
The research covers court decisions across the European Union, identifying relevant cases in Austria, Belgium, Croatia, Denmark, France, Germany, Spain and the Netherlands.
Some applicants successfully challenged decisions affecting their healthcare, while others were unsuccessful. The differences demonstrate how legal protections can vary between countries, even when patients face similar difficulties accessing treatment.
In Austria, for example, a Supreme Court decision in August 2025 found that a private health insurance exclusion affecting medically necessary gender-affirming treatment was discriminatory.
Germany has also seen significant legal disputes over healthcare funding, including a 2023 Federal Social Court ruling concerning insurance coverage for chest surgery sought by a non-binary patient.
Such decisions illustrate the complex relationship between medical assessments, insurance rules and patients’ legal rights.
The wider findings also reflect concerns identified through European LGBTQ+ research. A 2024 European Union survey found that 39% of transgender respondents reported discrimination by healthcare workers.
Long waiting lists, inconsistent eligibility requirements and difficulties finding specialist professionals can create additional barriers.
TGEU argues that legal challenges can help establish clearer responsibilities for healthcare providers and insurance organisations while offering opportunities to challenge discriminatory decisions.
However, the review does not introduce new EU-wide healthcare legislation or guarantee that previous judgments will apply automatically in other countries.
Instead, it provides lawyers, campaigners and transgender communities with examples of legal arguments that have succeeded or failed.
The findings may prove particularly valuable as courts continue considering disputes about access to treatment and the financial responsibilities of healthcare systems across Europe.
